(4) Subsequent events
In January 2024, the Group announced measures for Life Science to streamline processes to become more efficient, customer focused, and agile. The implementation of these measures will adversely impact profit before tax in a mid-double-digit million-euro amount in 2024.
No other events of particular importance that could have a material impact on the net assets, financial position, or results of operations occurred subsequent to the balance sheet date.